Pfizer hits stumbling block on Herceptin rival, but wins 'breakthrough' status on MenB vaccine
This morning’s news is a mixed bag for Pfizer $PFE, which reported updates on two different pipeline drugs first thing Monday. One program saw a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
